Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
21.2M
-
Shares change
-
+2.73M
-
Total reported value, excl. options
-
$348M
-
Value change
-
+$44M
-
Number of buys
-
20
-
Number of sells
-
-14
-
Price
-
$16.41
Significant Holders of MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) as of Q4 2018
39 filings reported holding MYOV - MYOVANT SCIENCES LTD - COMMON STOCK-FO as of Q4 2018.
MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.2M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (3.71M shares), BB BIOTECH AG (3.6M shares), NovaQuest Capital Management, L.L.C. (3.47M shares), JANUS HENDERSON GROUP PLC (2.56M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.2M shares), LORD, ABBETT & CO. LLC (1.91M shares), PRICE T ROWE ASSOCIATES INC /MD/ (811K shares), NORGES BANK (750K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (725K shares), and Bank of New York Mellon Corp (369K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.